Cesca Therapeutics Appoints Robin Stracey As CEO - Quick Facts

(RTTNews) - Cesca Therapeutics Inc. (KOOL), an autologous cell-based regenerative medicine company, announced that it has appointed Robin Stracey as Chief Executive Officer or CEO.

The company said Robin Stracey was appointed to the Board of Directors of Cesca Therapeutics in July 2011 and will remain a member of the Board. On October 29, 2014, the company announced that Stracey had been appointed to serve as Interim CEO.

Cesca Therapeutics noted that Stracey had previously served as the President and Chief Executive Officer at several companies, both public and private, and has over thirty years of experience in the global life sciences business.